Skip to main navigation
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Search
Close
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Press Release
Dec 20, 2022
| Susan Reilly
AAM Statement on the Consolidated Appropriations Act of 2023
Press Release
Dec 13, 2022
| Susan Reilly
AAM Statement on CMS's Proposed Rule Requiring Generic Drugs to be Covered on Generic Tiers
Video
Dec 2, 2022
| Erica Klinger
Back Together: GRx+Biosims 2022 Conference Recap
Video
Nov 30, 2022
| Erica Klinger
Desi is Back Playing Soccer and Doing "Normal Kid" Stuff
Video
Nov 28, 2022
| Erica Klinger
AAM's Erica Klinger speaks with Connor Nell and Brian Biehn from AmerisourceBergen #GBW2022
Blog
Nov 23, 2022
| Erica Klinger
Back Together: GRx+Biosims 2022 Conference Recap
Video
Nov 16, 2022
| Erica Klinger
Patient Perspective on the Value of Biosimilars During IGBA #GlobalBiosimilarsWeek
Press Release
Nov 14, 2022
| Susan Reilly
Raising Awareness for Biosimilars for Stakeholders Around the World
Blog
Oct 19, 2022
| Monét Stanford
Patients Pay More When Generic Drugs Are Placed On Non-Generic Tiers, Even Though Prices For Generics Are Going Down
Blog
Oct 14, 2022
| Jewel Smith
Member Spotlight: Meitheal Pharmaceuticals
Video
Oct 14, 2022
| Erica Klinger
Join Us at Access! 2023
Press Release
Oct 14, 2022
| Susan Reilly
AAM Statement on President Biden's Executive Order on Lowering Prescription Drug Costs
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action